Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis.

Granfors K, Merilahti-Palo R, Luukkainen R, Möttönen T, Lahesmaa R, Probst P, Märker-Hermann E, Toivanen P.

Arthritis Rheum. 1998 May;41(5):855-62.

PMID:
9588737
2.
3.

Inhibitory effect of 0 degree C storage on the proliferation of Yersinia enterocolitica in donated blood.

Bradley RM, Gander RM, Patel SK, Kaplan HS.

Transfusion. 1997 Jul;37(7):691-5.

PMID:
9225931
5.

Factors affecting growth of Yersinia enterocolitica in cellular blood products.

Högman CF, Engstrand L.

Transfus Med Rev. 1996 Oct;10(4):259-75. Review. No abstract available.

PMID:
8899955
6.

Differential contribution of Yersinia enterocolitica virulence factors to evasion of microbicidal action of neutrophils.

Ruckdeschel K, Roggenkamp A, Schubert S, Heesemann J.

Infect Immun. 1996 Mar;64(3):724-33.

8.
9.

Yersinia enterocolitica septicemia in autologous blood transfusion.

Haditsch M, Binder L, Gabriel C, Müller-Uri P, Watschinger R, Mittermayer H.

Transfusion. 1994 Oct;34(10):907-9.

PMID:
7940665
10.

Yersinia enterocolitica: guidelines for serologic diagnosis of human infections.

Bottone EJ, Sheehan DJ.

Rev Infect Dis. 1983 Sep-Oct;5(5):898-906.

PMID:
6356271
11.
12.

Serological diagnosis of yersiniosis by immunoblot technique using virulence-associated antigen of enteropathogenic Yersiniae.

Heesemann J, Eggers C, Schröder J.

Contrib Microbiol Immunol. 1987;9:285-9. No abstract available.

PMID:
3665507
13.

Drug susceptibility of Yersinia enterocolitica and Yersinia pseudotuberculosis.

Kanazawa Y, Ikemura K, Kuramata T.

Contrib Microbiol Immunol. 1987;9:127-35. No abstract available.

PMID:
3665490
14.

Optimal recovery of Yersinia enterocolitica 0:3 and 0:9 from stools of patients with intestinal disorders.

Van Noyen R, Selderslaghs R, Wauters G, Vandepitte J.

Contrib Microbiol Immunol. 1987;9:272-8. No abstract available.

PMID:
3311636
15.

Persistence of Yersinia enterocolitica in man.

Hoogkamp-Korstanje JA, de Koning J, Heesemann J.

Infection. 1988 Mar-Apr;16(2):81-5.

PMID:
3286508
17.

Growth and endotoxin production of Yersinia enterocolitica and Enterobacter agglomerans in packed erythrocytes.

Arduino MJ, Bland LA, Tipple MA, Aguero SM, Favero MS, Jarvis WR.

J Clin Microbiol. 1989 Jul;27(7):1483-5.

18.

Combined use of released proteins and lipopolysaccharide in enzyme-linked immunosorbent assay for serologic screening of Yersinia infections.

Mäki-Ikola O, Heesemann J, Lahesmaa R, Toivanen A, Granfors K.

J Infect Dis. 1991 Feb;163(2):409-12.

PMID:
1988526
19.

Update: Yersinia enterocolitica bacteremia and endotoxin shock associated with red blood cell transfusions--United States, 1991.

Centers for Disease Control (CDC).

MMWR Morb Mortal Wkly Rep. 1991 Mar 22;40(11):176-8.

PMID:
1900562
20.

Screening blood donors for gastrointestinal illness: a strategy to eliminate carriers of Yersinia enterocolitica.

Grossman BJ, Kollins P, Lau PM, Perreten JL, Bowman RJ, Malcolm S, Palko WM.

Transfusion. 1991 Jul-Aug;31(6):500-1.

PMID:
1853442

Supplemental Content

Support Center